Skip to main content

Table 1 Survival status of resected NSCLC patients according to La mRNA expression levels

From: The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB®

La expression (compared to healthy tissue)

Survival status

Number per group

 

Dead

Alive

 

>2-fold increase

103 (61%)

65 (39%)

168

<2-fold increase

133 (48%)

142 (52%)

275

  1. The mRNA expression of La and survival status of patients with resected NSCLC was examined using Oncomine, with data originally derived from[27].